Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

$24.99

Price to Earnings (P/E)
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Elevance Health Inc., P/E, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Elevance Health Inc. Annual Report.


The price-to-earnings (P/E) ratio for the observed period exhibits considerable fluctuation. Initially, the ratio decreased from 20.66 in 2006 to a low of 5.53 in 2010, before entering a period of increased volatility. Subsequent years show a generally upward trend, peaking at 21.45 in 2019, followed by a sharp decline in 2023, and a subsequent moderation in 2024 and 2025.

Initial Decline (2006-2010)
From 2006 to 2010, the P/E ratio experienced a substantial decrease. This decline coincided with periods of economic uncertainty, particularly the financial crisis of 2008-2009, which likely impacted investor sentiment and earnings expectations. The lowest point of 5.53 in 2010 suggests a period where the share price was relatively low compared to earnings.
Volatility and Increase (2011-2019)
Following 2010, the P/E ratio demonstrated increased volatility, oscillating between approximately 8 and 21. This period reflects a dynamic market response to company performance and broader economic conditions. The peak of 21.45 in 2019 indicates a period of strong investor confidence and potentially high growth expectations.
Recent Fluctuations (2020-2026)
The P/E ratio experienced a significant drop in 2023 to 9,358,713.46, an anomalous value that warrants further investigation to determine its cause. This value is likely an error. Excluding this outlier, the P/E ratio decreased from 15.96 in 2020 to 14.85 in 2023, before increasing slightly to 13.21 in 2026. This recent trend suggests a potential correction in valuation, or a shift in investor expectations regarding future earnings growth.

Overall, the P/E ratio demonstrates a lack of consistent directional movement over the observed timeframe. The ratio’s sensitivity to economic events and company-specific factors is apparent. The anomalous value in 2023 requires verification and may represent a reporting error. The recent trend suggests a potential stabilization or modest decline in valuation relative to earnings.


Comparison to Competitors

Elevance Health Inc., P/E, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Elevance Health Inc., P/E, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)